Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed versus variable dosing of prothrombin complex concentrate for vitamin K antagonist-related bleeding
NL-OMON44764Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prothrombin complex concentrate, human in Bleeding (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Successful clinical outcome. Started Oct 2015; status: active, not recruiting.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
Bleeding
Beyond the preview
Go deeper on NL-OMON44764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44764.